Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Clinical Management of Non-alcoholic Steatohepatitis
Author(s): Carlos Millán-Rodríguez , Carlos Palacios Castelló , María de Regla Caballero-Valderrama , et al Added: 2 years ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Ethical and Regulatory Frameworks Post-AI Act in Clinical Research
Author(s): Andrea Barucci , Valentina Colcelli , Salvatore De Masi , et al Added: 4 days ago

Digital Health

Guidelines & Statements
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice
Author(s): Michelle O'Donoghue Added: 2 months ago
AHA Scientific Sessions 2025 - Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) joins us to discuss the evolving understanding of the causal relationship between elevated lipoprotein(a) and atherosclerotic cardiovascular disease, and what this means for risk stratification and management strategies in clinical practice.Dr O'Donoghue begins by highlighting the importance for clinicians to… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Clinical Clues in Cardiovascular Disease
Author(s): Eva Gerdts , Faizel Osman , Yassir Javaid Added: 4 months ago
This six-part interview series, recorded around ESC 2025, brings together leading experts to share strategies for earlier and more accurate detection of cardiovascular disease. The discussions highlight how atypical or subtle symptoms of stroke and heart failure can delay diagnosis, and why vigilance in routine practice is critical.The series also examines sex-specific differences in cardiac… View more

CV Disease in Special Populations

Electrophysiology & Arrhythmia
ADA 25: Clinical Implications of STRIDE for Endocrinologists
Author(s): Added: 6 months ago
ADA 2025 - We are joined by Dr Alice Cheng (University of Toronto, Toronto, CA) to discuss the clinical implications of STRIDE (NCT04560998). The placebo-controlled study investigated whether semaglutide with standard-of-care treatment has an effect on walking ability in patients with PAD and T2D. The primary outcome measure was the change in maximum walking distance on a constant load treadmill… View more

Cardiovascular Renal Metabolic

Vascular Disease and Surgery
ESC 25 Guidelines Discussion: Management of Dyslipidaemias
Author(s): Harriette Van Spall , Jeanine Roeters Van Lennep Added: 4 months ago
ESC Congress 2025 - Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Professor Jeanine Roeters van Lennep (Erasmus Medical Center, NL) to discuss the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.This focused update delivers the most current, evidence-based recommendations for lipid management and cardiovascular risk… View more

Guidelines & Statements

Prevention & Chronic Conditions
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial
Author(s): Harriette Van Spall , Mandeep Mehra Added: 2 years ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more

Heart Failure

Electrophysiology & Arrhythmia
Pulmonary Embolism Management
Author(s): Andrew SP Sharp , Gilles Lemesle , Start date: Oct 07, 2025
Pulmonary Embolism (PE) remains a leading cause of cardiovascular morbidity and mortality, requiring timely intervention and coordinated multidisciplinary care. This session will provide an in-depth analysis of the current PE treatment landscape, including the latest clinical trial updates (HI-PEITHO, PEERLESS), institutional decision-making workflows and collaborative patient management… View more

Intervention

Vascular Disease and Surgery
ESC 25 Guidelines Discussion: Management of Cardiovascular Disease and Pregnancy
Author(s): Harriette Van Spall , Julie De Backer Added: 4 months ago
ESC Congress 2025 - Late-breaker host Dr Harriette Van Spall (McMaster University, CA) joins Prof Julie De Backer (University Hospital Ghent, BE) to discuss the newly released 2025 ESC Guidelines for the Management of Cardiovascular Disease in Pregnancy. Together, they highlight key updates, critical advances in maternal cardiovascular care, and evidence-based recommendations tailored for this… View more

CV Disease in Special Populations

Guidelines & Statements
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy
Author(s): James Burton , Clara Bonanad Lozano , Aaron Wong , et al Start date: Jul 02, 2025
.img-row:after { content: ""; clear: both; display: table; } .img-column { float: left; width: 50%; padding: 5px; } @media screen and (max-width: 500px) { .img-column { width: 100%; } } Join James Burton (University of Leicester, Leicester, UK), Clara Bonanad (University Clinical Hospital of Valencia, Valencia, ES), Aaron Wong (Princess of Wales Hospital, Bridgend, Wales, UK)… View more

Cardiovascular Renal Metabolic

Heart Failure